We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Like mushrooms

8 January 2015 By Robert Cyran

Moderna’s the latest to be worth at least the $1 bln that earns the moniker of the mythical beast. It aims to develop 100 drugs in 10 years. That’s laudable, but the technology may not work in humans. Moderna’s valuation is another sign the biotech boom’s flirting with fantasy.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)